Skip to main content

Advertisement

Table 2 Distribution of Fib-4 scores in coded NAFLD/NASH patients shown for each country database

From: Risks and clinical predictors of cirrhosis and hepatocellular carcinoma diagnoses in adults with diagnosed NAFLD: real-world study of 18 million patients in four European cohorts

Risk category HSD Italy (%) IPCI Netherlands (%) SIDIAP Spain (%) THIN UK (%) Total population (%)
Low (< 1.30) 64.7 69.7 65.3 63.4 65.4
Indeterminate (1.30–2.67) 31.0 26.6 30.1 26.2 29.8
High (> 2.67) 4.3 3.7 4.6 10.5 4.7